Related Experiment Videos

Identification of an antisense WT1 promoter in intron 1: implications for WT1 gene regulation

K T Malik1, J I Wallace, S M Ivins

  • 1Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, UK.

Oncogene
|October 19, 1995
PubMed

Insights

Researchers discovered a new WT1 gene promoter that regulates Wilms' tumour suppressor gene expression. This antisense promoter activity can be used to down-regulate WT1 levels, offering potential therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The Wilms' tumour suppressor gene (WT1) is crucial for kidney development and its proper regulation is vital.
  • Dysregulation or loss of WT1 function is linked to Wilms' tumour, a pediatric kidney cancer.

Purpose of the Study:

  • To investigate novel regulatory mechanisms of the WT1 gene.
  • To identify and characterize a potential antisense promoter for WT1.

Main Methods:

  • Utilized luciferase reporter gene constructs with DNA sequences from the WT1 gene's first intron.
  • Analyzed transcriptional activity and regulatory elements of the identified antisense promoter.
  • Mimicked antisense transcript expression to assess WT1 down-regulation.

Main Results:

  • Identified a functional antisense WT1 promoter operating in the opposite direction to the main 5' promoter.
  • Demonstrated that WT1 expression reciprocally regulates its own antisense promoter activity.
  • Showed that antisense mRNA targeting WT1's first exon effectively reduces cellular WT1 levels.

Conclusions:

  • The WT1 gene possesses a reciprocal antisense regulatory mechanism involving a novel promoter.
  • Antisense WT1 promoter activity plays a role in the intricate regulation of WT1 gene expression.
  • Targeting WT1 with antisense mRNA offers a potential strategy for down-regulating its expression in relevant contexts.

Related Concept Videos